Bahl & Gaynor’s Allergan Inc AGN Stock Holding History

Bahl & Gaynor’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,182	Closed	-$464K	–	443
2014 Q4	$464K	Hold	2,182	–	–	0.01%	304
2014 Q3	$389K	Hold	2,182	–	–	0.01%	321
2014 Q2	$369K	Hold	2,182	–	–	0.01%	314
2014 Q1	$271K	Hold	2,182	–	–	﹤0.01%	352
2013 Q4	$242K	Buy	+2,182	New	+$208K	﹤0.01%	352

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Bahl & Gaynor's AGN Position: Q1 2015 in Review

Bahl & Gaynor sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,182 shares — an estimated $464K sold.

Bahl & Gaynor first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $464K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Bahl & Gaynor reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Bahl & Gaynor sold 2,182 Allergan Inc shares in Q1 2015, an estimated $464K.
Bahl & Gaynor first reported a position in Allergan Inc in Q4 2013 and held it in 5 quarters.
Bahl & Gaynor's Allergan Inc position peaked at $464K in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Bahl & Gaynor's 13F filing for Q1 2015, filed 12 May 2015.